tiprankstipranks

David-Alexandre Gros Insider Profile

4 Followers
David-Alexandre Gros, CEO, Director at Eledon Pharmaceuticals, holds 168.66K shares in Eledon Pharmaceuticals (Ticker: ELDN), holds 0.00 shares in Alnylam Pharma (Ticker: ALNY), holds ― shares in Neurocrine (Ticker: NBIX).
tipranks
David-Alexandre Gros

David-Alexandre Gros
Eledon Pharmaceuticals (ELDN)
CEO, Director

Ranked #97,093 out of 108,921 Corporate Insiders

Profitable Transactions

0%
0 out of 4 Profitable Transactions

Average Return

-42.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$494K
100.00%
0.00%
0.00%
A breakdown of David-Alexandre Gros's holdings

Insider Roles

Eledon Pharmaceuticals
(ELDN)
CEO, Director
Alnylam Pharma
(ALNY)
SVP, Chief Business Officer
Neurocrine
(NBIX)
President & COO
Roles that David-Alexandre Gros holds in companies

Most Profitable Insider Trade

Stock:
Alnylam Pharma
(ALNY)
Rating:Informative Buy
Date:Feb 24, 2016 - Feb 24, 2017
Return:-19.60%
The most profitable trade made by David-Alexandre Gros

David-Alexandre Gros's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Eledon Pharmaceuticals
Aug 04, 2026
CEO, Director
Uninformative Buy
$494.18K
Alnylam Pharma
Feb 24, 2016
SVP, Chief Business Officer
Informative Buy
62.75K
$0.00
Neurocrine
President & COO
List of latest transactions for each holding click on a transaction to see David-Alexandre Gros's performance on stock

David-Alexandre Gros insider profile FAQ

What is the percentage of profitable transactions made by David-Alexandre Gros?
The percentage of profitable transactions made by David-Alexandre Gros is 0%.
    What is the average return per transaction made by David-Alexandre Gros?
    The average return per transaction made by David-Alexandre Gros is -42.30%.
      What stocks does David-Alexandre Gros hold?
      David-Alexandre Gros holds: ELDN, ALNY, NBIX stocks.
        What was David-Alexandre Gros’s latest transaction?
        David-Alexandre Gros latest transaction was an Uninformative Buy of ―.
          What was David-Alexandre Gros's most profitable transaction?
          David-Alexandre Gros’s most profitable transaction was an Informative Buy of ALNY stock on February 24, 2016. The return on the trade was -19.60%.
            What is David-Alexandre Gros's role in Eledon Pharmaceuticals?
            David-Alexandre Gros's role in Eledon Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.